Peptides, Bioregulators, and the Future of Longevity Science

In this insightful episode of Ageless and Timeless, host Michele Hughes is joined by
Jessica Alana, a Dubai-based regenerative health consultant and student in the world’s
first Master’s program in Longevity Science from Geneva College. Jessica opens up
about her personal journey into health and wellness, which was deeply influenced by
the loss of her mother and her passion for cellular therapies.

Jessica and Michele dive deep into the revolutionary role of peptide bioregulators and
regenerative medicine in extending healthspan. They explore the differences between
general peptides and bioregulators, discuss the critical importance of telomere length
and biological age, and share how diagnostics like DNA methylation testing are shaping
the future of personalized health.

Jessica also shares her experiences with hyperbaric oxygen therapy, her involvement in
Dr. Bill Lawrence’s peptide bioregulator clinical trials, and her insights on GLP-1
medications like semaglutide when used responsibly. She offers a pragmatic and
science-backed perspective on how peptides can be safely stacked for immune, joint,
and cellular health—and emphasizes that lifestyle remains the foundation for long-term
wellness.

Whether you're new to peptides or exploring advanced biohacking strategies, this
episode delivers a clear and empowering roadmap from one of the emerging voices in
regenerative health.

For more information on Peptides and Bioregulators to Reverse Biological Age! Click
the link to access Jessica Alana’s slide show:
https://drive.google.com/file/d/156dupsW74yFRxk71rrKUHNzt1FQjLsNS/view?usp=driv
e_link

Connect with Jessica Alana:
�� Website www.jessicaalana.com
�� Email: [e-mail]
�� Instagram: @jessicaalana
Medical Disclaimer – Ageless and Timeless Podcast

Ageless and Timeless (the “Show”), along with its host and guests, shares insights and
discussions on health, wellness, and longevity for informational and educational
purposes only. The Show does not provide medical advice, diagnoses, treatments,
cures, or preventative recommendations for any disease or health condition. The
content shared should not be used as a substitute for professional medical advice,
diagnosis, or treatment.

While we strive to feature reputable sources and knowledgeable guests, neither
Ageless and Timeless nor its host or affiliates assume responsibility for errors,
omissions, or misinterpretations in the information provided. Listeners are encouraged
to use their own discretion and consult with a licensed medical professional before
making any health-related decisions. By listening to this podcast, you acknowledge that
any actions you take based on the information presented are at your own risk, and
Ageless and Timeless, its host, guests, and affiliates are not liable for any direct,
indirect, incidental, or consequential damages resulting from the use of this content.

Episode Transcript

Speaker 1 (00:09):
Good morning everyone. This is Michelle Hughes from Ageless and Timeless.
Today we have a guest who's coming to us from
Dubai and boy, I was way off on the time,
but it's ten pm there, so her name is Jessica
Alana and welcome Jessica.

Speaker 2 (00:27):
Hi, Hi, Michelle. How you were.

Speaker 1 (00:30):
So happy to have you here today and thank you
for staying up for us.

Speaker 2 (00:34):
So welcome.

Speaker 1 (00:35):
Because of the time, yeah, because of the time difference,
Jessica's not going to appear on video. We didn't realize
it was so late there, so you'll see me and
Jessica will stay on an audio, but we are going
to have a little presentation later that she prepared, if
we don't run out of time first. So we'll see

(00:56):
if that works and that will be a video. So, Jessica,
I was reading your background and I am so so
sorry about your loss with your mother, and i'd like
you to tell us a little bit about that history
and how that has changed you as a human being,
as a person, if you don't mind, Is it okay

(01:18):
to talk about it?

Speaker 2 (01:20):
Yeah, it's okay. I don't mind giving you a brief overview.
So I lost my mom in twenty twenty one to
mental health issues, and it was a really hard time
for me and my family. My mom was actually a major,
you know, a major reason for me going into the

(01:41):
health industry and getting my biomedicine degree and also my
master's and longevity science from Geneva College. So she had
a huge inspiration.

Speaker 1 (01:52):
On my life.

Speaker 2 (01:53):
And I think, you know, losing someone in that way,
it's definitely empowered me to be compassionate and have a
lot of empathy, and I think this goes a long
way within the health industry.

Speaker 1 (02:08):
So it's interesting that you didn't go into mental health
per se as a result of that tragic event. Do
you incorporate mental health with your other protocols that in
your consulting practice that you're currently involved.

Speaker 2 (02:25):
With, Not so much necessarily. I prefer to work with
therapies at the cellular level, so peptides and bioregulators and
regenerative medicine. I myself, I'm actually a big fan of psychology.
It's actually a hobby of mine. I do like reading

(02:46):
a lot of psychology books. But I'm not trained nor
qualified to work in mental health. So what I stick
to is what I know, right.

Speaker 1 (02:55):
That's perfect well, of course mental health does play a
role in every thing in longevity. So and of course
we know the gut and the brain access are critical.
In fact, today I was just having a conversation about
that with one of my colleagues and you know, we're
he's having an issue and one of his children, and

(03:17):
I said, you know, if you're to deal with depression
and anxiety and mental health, you need to start with
the gut. And everybody is toxic to some degree if
you can't live in today's modern world without being exposed
to toksin. So the gut is where you know, ninety

(03:37):
eighty seventy to ninety percent of your immune system is
in your gut, and all ninety percent of serotonin is
made in the gut, so serotonin being feel good like
dopamine and the neurotransmitter. So you can't escape this with
any of the practice that you're currently doing. So why

(03:59):
did you go to Genie vote since you're I mean,
you are in Dubai now, But were you in Dubai
and then went to Geneva or what exactly was the
logistical chronological event?

Speaker 2 (04:13):
So I have my degree in biomedicine from the UK
and then very recently, I've decided to undertake a masters
in longevity science. It's actually the world's first Masters in
longevity science and it's run by Geneva, Switzerland College. So
it can be done remotely or it can be done

(04:33):
at the campus. So at the moment, I'm completing the
majority of the course remotely and I will go to
the campus at some point, maybe to do my hypothesis
or maybe to meet my fallow students.

Speaker 1 (04:47):
Excellent, excellent. So I don't think we have a degree
in longevity science in the US at this time, Dewey,
do you know.

Speaker 2 (04:56):
Any I don't think so. I know that Geneva College
was the first, so maybe they'll be rolling that out
into the US. But we do have a lot of
international US students of the Geneva College.

Speaker 1 (05:11):
Yeah, so that so, what what is the curriculum? Just
give us a little taste of what you had to
study to get to get to this level.

Speaker 2 (05:22):
You mean, what's the curriculum inside the inside the master's programs.

Speaker 1 (05:28):
To earn a master's degree? What kind of court and
longevity science? What kind of courses did you have? Do
you have to take?

Speaker 2 (05:36):
So we have to learn about apigenetics, so we have
to understand how the mitochondrial DNA works within apigenetics and
also messenger DNA. And also I'm actually only a few
lectures through the course, but we have some really interesting
lecturers and you know, we'll run out PhDs and longevity experts.

(05:59):
So I'm still happy. And the cool curriculum is available
online for anyone who wants to look at that.

Speaker 1 (06:05):
Mm hmm. So what what what course did you resonate
with the most?

Speaker 2 (06:12):
Actually I'm only a few lectures through, so I'm still
working my way through. But I really like learning about
the messenger RNA when it comes to anti aging.

Speaker 1 (06:26):
Yeah, you know, the DNA Company is one of my
very close colleagues. Are you familiar with them? They do
the epigenetic testing in Toronto.

Speaker 2 (06:39):
Yeah, I know quite a few, quite a few epigenetic
taxting companies.

Speaker 1 (06:44):
Right, Well, that one, I think is probably the number
one because they do they never sell your data. You know,
they're uh, you know, you know twenty three and me
is going bankrupt or has gone bankrupt. But you know,
most of these companies have been guilty of using your
data and you're you know, without your knowledge. So this

(07:04):
is a big issue. In genetic testing and epigenetic testing.
So DNA company absolutely number one does not use your data.
It's all private, and then they send you your results
in a sixty page test result where you can also
then have an app that you go online because it's

(07:26):
very I don't know how you feel, Jessica, maybe you
could tell us, but it's kind of daunting because they
have all these different genes that with all these different labels,
and when you're a lay person trying to understand what
these genes are and how you know what they represent,
you'd need a year long course just to study that,

(07:49):
I think so. But this app allows you to go
online and look onder headings like cardiovascular health or brain
health or gut health, and then under that they have
the genes that are corresponding with those areas those categories,
and then they tell you whether you are optimal suboptimal.

(08:13):
But the big thing, and this is something that I'm
sure you're learning and your your courses, you don't have
to be like it doesn't have to be like a
sentence of death and destruction if you get a suboptimal
epigenetic rating on any one of these measurements, because epigenetic

(08:35):
means lifestyle. So if you're genetically you have one, you know,
a suboptimal gene, that doesn't mean it's going to get expressed.

Speaker 2 (08:46):
Yes, it's true, it's dicorrect. It's based on histone modifications
and methylation and some other transcription and translation factors as
to while the genome will be expressed and all. So
if it is happy genetic, you can positively influence that
by regenerative medicine and lifestyle modifications, good food, good diet,

(09:09):
good relationships and that type of thing.

Speaker 1 (09:12):
And that's everything that they go through with you, you know,
and they did what they have follow ups. You're nice, Yeah,
you know, I know. I connected you with doctor Bill Lawrence.
We'll talk about the peptide bioregulators. But i'd love to
connect you with Kashif Khan and who is the co
founder or founder actually and Tracy Wood is the current CEO.

(09:37):
Kashif stepped aside to be business development, but I'd love
to connect you. I think they'd be an incredible contact
influence for you as you're going through your coursework. So
if you want that after offline, I'll be happy to
I'll be happy to send send it a digital introduction
for you.

Speaker 2 (09:58):
Oh, that would be amazing, thank you, so lunch, Well,
they probably appreciate tide, you.

Speaker 1 (10:02):
Know, Jessica. They probably want you to take the test
and then use that as a benchmark for you know,
relationship going forward, which is exactly what I did. So yeah, anyway,
well we'll talk about that later. So European Wellness, founded
by the iconic and widely published professor doctor Michael Chan,

(10:23):
is the world leader in stem cell and peptide therapy,
with twenty six medical and aesthetics BA locations primarily in
Europe and Asia. Their website www. Dot Europeanwellness dot com
details the wide range of wellness products that can be
ordered using the age's code for a ten percent discount.

(10:44):
They will also offer our viewers discounts on medical and
cosmetic services and products that they choose to visit the clinics.
I have firsthand experience using their wide range of science
based stem cell and peptide products and are now a
loyal customer. Go to their website Www. European Wellness dot

(11:04):
com for more information about this exciting company. Let's jump
forward to the most important issue that brought us together,
and that's peptide bioregulators. This is like probably one of
the hottest topics today in functional medicine and peptizing general,

(11:29):
but more specifically and more narrowly peptide bioregulators. So what
was it that brought you to that awareness so that
you reached out to me to introduce you to Bill Lawrence.

Speaker 2 (11:43):
So I've been working in the regenerative Madison space since
twenty twenty one, and I actually started off with hyperbioical
oxygen therapy. So I was working in the Wellness Lab,
which is number one hypak in London, and they had
some very beautiful hyperbaric oxygen machines. And after learning about

(12:05):
hyperbaric oxygen, I became very interested in other ajubant therapies
and one of these being peptides. So peptides are typically
between four and fifty amino acids and chain land and
once I kind of figured out peptides, I stumbled on
to bioregulators. And I actually got to know bioregulators from

(12:30):
a very good friend of mine, Dean Henry.

Speaker 1 (12:34):
Maybe you know him.

Speaker 2 (12:35):
He's the founder of U A E Peptides and he
knows doctor Cavinston very well. You know he knew him,
and yeah, so Dean actually introduced me to the oral
peptide oral peptid bioregulators. And in the beginning I was
kind of confused because there wasn't too much literature on them.

(12:56):
This was early twenty twenty three, and they were harmy
being touched upon in early twenty twenty three, and most
of the literature I found with either a Russian translation
or it was from Russia or Ukraine or those eastern
European countries, and it was hard to find, you know,

(13:17):
any literature or second in the third hand writing about
the oral pepti bioregulators within the West. So I kind
of I kind of figured out that, you know, at
their core, their appy genetic switches, and then I found
some interesting presentations, and then I stumbled across well, of course,
I found the Calvenston's work on PubMed, and in the

(13:40):
beginning I wasn't even sure if his work was available
on part MAD, but actually, you know, in the end,
I did do a pub Med search on his name,
and it brings back all of his studies in English,
and also his website, I think it's Calvinston dot info
has all of the studies in English as well. So
then in the end I just stumbled across the research.

(14:02):
And then one of the biggest advocators of peptide bioregulators
in the US, and an individual who was carrying on
all of the knowledge in doctor Cabinston's work, is doctor
Bill Lawrence. So I listened to your podcast with him,
which I thought was absolutely amazing. I'd never heard of
the oral peptide bioregulators being talked about in so much

(14:26):
debt by a Western PhD or Western doctor, so for
me that was very interesting.

Speaker 1 (14:35):
And didn't you you've joined his clinical trials.

Speaker 2 (14:39):
Correct, I have, that's right, I haven't. I recommended a
lot of people to join his trials as well. I
told a lot of my close friends and my community.
I'm pretty sure more than a handful of joined, So
I think there was a good outcome for everyone.

Speaker 1 (14:56):
Oh good, I knew. He said that there were a
couple of people I think from Geneva, right, your associates.

Speaker 2 (15:04):
Yeah, yeah, a few people from Switzerland, some friends from
Norway as well. I think maybe some people from Dubai
in the UK too.

Speaker 1 (15:13):
Oh okay, So I didn't know that. He's been very
transparent with me about all the work he's doing because
I'm in his clinical trials. I've been in for I
think it's two years now, and I just took my
second test. You took the true diagnostics and the spectro
cell correct.

Speaker 2 (15:33):
I haven't yet. I've been a little busy, but I
definitely will soon.

Speaker 1 (15:40):
Yeah, in order for him to start working with you.
Those are the baselines. So just so everybody, anybody that's listening,
if you are in the medical field. He has a
clinical trial doctor Bill Lawrence in Atlanta, Georgia. He's absolutely
does not want people to call him directly, so I

(16:00):
to screen everybody because he's so busy. I mean, you
can imagine with over one hundred people in his clinical
trials and he's following everybody. But he does tell me
that if I have anybody that is interested that's in
the medical world, because there is a fee, as you know, Jessica,

(16:22):
to be in the clinical trials, and it's a lower
fee if you're a medical professional. There's still a concierge
clinical trial position for a consumer, but the fee is
much higher. So I don't even encourage anybody who's not
a medical professional, but if you are, you're interested in

(16:45):
either way, you can always reach me at my Ageless
and Timeless website. There's a phone number and an email.
But anyway, moving on, the true diagnostics is a methylation measurement,
so it gives you your biological age versus your chronological age,

(17:07):
which we'll talk about in just a moment, because that's
a key element to the baseline for beginning these peptide bioregulators.
And then you know, it measures your DNA methylation, which
it means you know your toxicity level and how your
epigenetics or your genetics affect your how quickly you methylate.

(17:32):
And I don't know about you, but I found out
from doing the DNA test that I'm a slow methy later,
so that gene was suboptimal. The good news was that
the APO four, which is the Alzheimer's that was normal
the Alzheimer's gene, and then the there was another one

(17:54):
that they do that was normal, which was a big one.
I can't remember which which one it was, but it was.
So it was such a relief to have. So I
wasn't surprised about the methylation because I think a lot
of people have that suboptimal gene. Again because of the
toxicity in our world, it's very unusual to find people

(18:17):
who can get rid of toxins on based on just
on their genetics. So there has to be a lot
more to it than the lifestyle, as we both know.
But then the other tests, the spectro cell test measures
your telomere length. And if anyone is following this, it

(18:37):
had been listened to my other podcasts, you know that
your telomeres, and Jessica can certainly confirm this. They're really
one measurement of your biological aging. So, Jessica, why don't
you explain what a telomir is.

Speaker 2 (18:54):
Yeah, So, tlomeir is all the protective caps at the
end of chromosomes that basically stop the double helix DNA
from unraveling. And essentially, so if you can imagine a shoelace,
you know that plastic protective cap at the end of
a shoelace, you know, obviously protects the shoelace strands from unraveling. Well,

(19:18):
as you age, those protective chromosome caps telomere caps which
protect the chromosomes become more degraded and just get shorter
and shorter, and therefore the chromosomes begin to unravel, and
this basically translates into faulty genome processing, and therefore you

(19:39):
have mistranslation of proteins. And you know, as you know,
the mistranslation of proteins is kind of where a lot
of aging and disease begins.

Speaker 1 (19:48):
Yeah. I think that's a really, very very good description,
and I think the simplest way to say that. Look,
in this case, longer is better. You don't want short telomeres.
That means you're da is splitting and you're getting getting
every time there's a cellular DNA or telomere split, they
get shorter. But the longer they are, the younger you are.

(20:12):
Is that a fair simplistic way to say it.

Speaker 2 (20:16):
Yeah, of course. And actually today there's only I think
two therapies that have shown significant impact on increasing telomere
land and the first one is hyperbaric oxygen, so this
was shown by the Israeli group led by doctor Shia Frtti.

(20:37):
And the second one is the bioregulator appitalent.

Speaker 1 (20:42):
Right exactly. Yeah, for a while, there was the TA
sixty five, if you remember, and everybody was touting you
go to the shows, and they were always there was.

Speaker 2 (20:52):
Always I hadn't heard of that.

Speaker 1 (20:54):
Maybe that was my era, and I think if you
talk to Bill Lawrence, she'll tell you that the peptide
by regulators are one of the ways to lengthen your telomeres.
And that's why they do the baseline because they want
to see how the peptides will affect over over time. So, yeah,

(21:14):
you know, that was the one great thing. When I
did it originally with Bill back two years ago, he
said he had to send the test back to spectro
cell because he never had a result with someone chronologically
of my age that was so biologically my telomeres were
an infant of one to five years old or zero

(21:37):
infant of five years old. He said he couldn't believe
the results, so he sent it back to see if
they had made a mistake, and sure enough they didn't.
They hadn't. So we'll see what this current one after
two years, what the current one does. But that was
like a really good outcome. Well, let's talk about biological

(21:58):
and chronological age. And just before we leave that subject,
I just want to say, because we'll come back to
the general subject of peptide bioregulators, but just so everybody
understands what Jessica just said is the bio peptides are
amino acids, so the peptide bioregulators have fewer amino acids,

(22:23):
usually less than fifteen, whereas the other peptides that you're
hearing so much about that are usually injectable, although they're
coming more and more becoming more and more available as
nasal sprays and some oral integrative integrative peptides that they'll
be on my podcast in a couple of weeks. Lori

(22:46):
and Kent Holdsorf they do the oral version. But anyway,
the differences between peptides generally and peptide bioregulators are the
number of amino acids and that the yan regulators are
all oral, whereas the general peptides like ipra morelen and

(23:09):
sam marellen and you know all the others, even insulin.
If people know that the original peptide is insulin, correct, Jessica.

Speaker 2 (23:21):
Yeah, in the nineteen forties, I'm pretty sure they developed insulin,
and yeah, that was the original founding peptide.

Speaker 1 (23:29):
Nobody ever knew or did anything with pep guides until
about ten years ago, right, So then now they've become
the darling of the longevity world, as I mentioned, And
so just so you know, if you're doing peptid bioregulators,
which you can get this. Doctor Cavinson is the.

Speaker 2 (23:49):
Original original, Yeah, and he.

Speaker 1 (23:52):
Was assigned to that role by Putin. That doesn't diminish
his impact as he could have. He could have won
a Nobel Prize. I don't know why he didn't, but
he's unfortunately passed away last year, so it would have
to be posthumous now. But he was assigned because of

(24:14):
Chernobyl and because the astronauts and they were seeing more
and more toxicity and these people that and the athletes too,
So he said, we want to find a way to
address this problem, and Caviinson was given that assignment. And
so just a little history if anyone wants to know

(24:36):
that Bill Lawrence being who the kind of guy he is,
he's like incredibly proactive, and he had a family history
of early demise and he was at that time, I
think when he first started looking into this, he was
in his seventies early seventies, and most of his family
had passed away before they ever reached mid seventies. So

(24:58):
he said, I don't want this to be my fate,
and I want to find the answers. And he's a
very successful real estate developer, just like you know. He
and I have the same background and came to functional
medicine and you know, very different ways. But his was
really because of his personal challenge of wanting to extend

(25:19):
his life. And so he discovered Cavinson just like you did.
You know, you discovered him, and he's researched it, and
to his credit, he got on an airplane and went
to the Soviet Union to Saint Petersburg, knocked on the
door and took Cavinson's credit. They took him in and
they trained him, and they they saw him as a

(25:39):
real opportunity to expand the peptipe by regulators in the
United States, which at that time they had been forty
years in the in Russia but sold in drug stores,
I mean, you know, easily obtained. So doctor Bill Lawrence,

(26:00):
who is a PhD, not a medical doctor, became the
spokesperson and the steward for expanding the peptides here in
the US. So that's just a little bit of background.
And by the way, they the other thing about the bioregulators,
they address individual organs. So let's just say, Jessica, you

(26:24):
know this because you know, Bill designs the protocol when
you're in his clinical trials according to your testing. And
so if he sees and he asks you interviews you
as well. But if he sees that you have a
weakness in let's say your heart, he'll design the program

(26:48):
to focus more on the peptides that target the heart.
So in a way, they're like stem cells that are pluripotent.
They they target the organ that most needs to be
addressed because of them its weakness. So every person is customized.
So you'll find that as you get going with him

(27:10):
that he'll be interviewing you so that you'll know exactly
how to customize your program. And you normally you take
the peptides ten days a month, so ten days on,
twenty days off, so and during that time we take
probably five to six or seven different peptides and orally

(27:33):
and then for ten days and then you take a
rest and then come back to them after the next round.
So yeah, there will be interesting. This will be my
way of telling you. I'll come back to you and
to my viewers to let you know how they have
affected my personal journey where you know, a very healthy

(27:58):
person is doing this without health issues. So I'll be
interested to seeing going back now to the biological versus chronological,
So tell me what your definition of chronological versus biological
aging is and how you would guide people to understand

(28:18):
how important knowing your biological age is in your health journey.

Speaker 2 (28:24):
Yeah, so chronological age is pretty simple to define and
explain and understand, and it's basically the number of years
that you've lived on planet Earth. So chronological age is
pretty easy. Biological age is a bit more complex, but
basically it's the age that yourself tissues organs and system

(28:49):
and behaving as. But even biological age can be classified
into immune age, cognitive age, anabolic age, all these different
further classifications, and also the way that biological age is
measured can also be further classified. So some people would

(29:10):
rather take an epigenetic clock as we've spoken about based
on DNA metholations happens. Other people will take a talomeal lens.
Some people will look at the glycans, so the balance
of pro inflammatory and anti inflammatory glycans. And with AI
and all this deep learning, you know, there's so many
new ways to combine multiple blood markers to bring out

(29:34):
an overall you know, biological age. So biological age is
a bit more complex and in of itself, it's a
whole topic and concept to understand, but essentially it's the
kind of numerical age that your cells are behaving as,
which obviously dictates you know the system and proxy you
use an individual.

Speaker 1 (29:56):
Yes, And we say every time we get into the
subject that you you are as old as yourself. So
all aging begins and ends in the cells. But however,
true diagnostics, which measures the DNA methylation, is now technologically
so advanced that they've added a way when you do

(30:17):
their blood test to measure the health of each of
your organs. Now I don't yeah, that's going to be
exciting if you haven't done that test yet. I just
did it yesterday, the second time, So the first time
they didn't have that available. So now they've combined two protocols,
the original with the new one that will tell you

(30:40):
so much more information that measures up and then they'll
give you a number of how all this tallies up
to your biological age. So very exciting. What's happening. An AI,
of course has been a big part of this, but
they've been working with some of the leading I think
it's Cornell University is where they doing a lot of

(31:00):
their research. So yeah, so this is something everybody should
be aware. I think everyone should take that true diagnostic test, honestly.

Speaker 3 (31:10):
Now there are others, but I think they're the leader
in the field, and that's why you know, doctor Lawrence
uses them exclusively for his baseline.

Speaker 1 (31:22):
So you mentioned the in terms of the UH, the
the biological age that the cells are so important, and
so I don't know yet whether true diagnostic is able
to measure the health of your cells. That's something I
would need to ask them. The health of your organs

(31:44):
is a you know, key indicator of the health of
your body, but whether it goes into the mitochondria and
the atp of that, I don't know. Are you Are
you aware of anyone that's doing the measuring your the
health of your cells.

Speaker 2 (31:59):
I don't know anyone who's doing that commercially. But I
think if there was a way to look at how
your mitochondrial DNA is being expressed, which is a whole
other part of the geno, we think that possibly could
be a good indicator. I think there's tasks out there

(32:21):
which can give a rough estimation of how much atp
SHO a dynascene tried phosphate yourselves are making, but I
don't think it's it's very accurate, like you're more likely
to get a false positive. I think mitochondrial DNA, if
someone can measure that, then then that that could be

(32:45):
what a good outcome, you know.

Speaker 1 (32:48):
I think the DNA companies does measure, but it's just
pure genetics, which we both know is not a you know, yeah,
that can be altered by your lifestyle. So I don't
know if it's completely giving you the biological or the
meta the biophysical uh, measurement of your cells. That's something

(33:10):
that we need to check into that. So which of
the peptizers had the most scientific backing in your experience?

Speaker 2 (33:21):
I think thimos and alpha one, So timosinal for one,
it is a FDA approved I'm unvaccinated, so it's not
that you know, these governing medical bodies have too much
influence on my train of thought. But if something is
aftera approved, then you know by proxy it has a

(33:43):
lot of clinical you know, human clinical trials. So I
know that thimosin alpha one is patented under the drug Namesadaxin,
and it's owned or was owned by Cycling Pharmaceuticals, which
is worth a couple of one hundred million dollars. So
I know that themUS and alpha one has a lot
of clinical backing, So in my opinion, it would be

(34:06):
pemos and alpha one, which isn't the most raved about
peptide because it solely focuses on the thymus gland and
the immune system, which is my favorite topic. Everyone loves
BPC one five salent, right, but simos and one is
probably the one with the most backing.

Speaker 1 (34:25):
Well, and keep in mind, for anybody that's watching today,
what Jessica's talking about are the regular the peptides, Yeah,
not the peptide bioregulators. However, the peptide bioregulators have targeted
the thymus gland. There is one Russian name you know,

(34:48):
translates over to the thymus gland, just as there's another
one for the bone marrow and so forth. So again
keep in mind, these are two distinct categories of peptides,
so the thymbras and alpha one in the normal peptide,
the original peptide is usually injectable, although have you seen

(35:12):
that there are more and more available now to take orally?

Speaker 2 (35:17):
Yeah, I have a little bit of an issue with
the mass production of oral available peptides. For example, I
saw an advertisement of orally available SS thirty one. Now
SS thirty one is a synthetic, you know, quite fragile

(35:40):
mitochondrial peptide that is involved in repairing the in a
mitochondrial membrane, and I don't think it's commercially ethical to
sell a product which I don't think will have a
high uptake into the mitochondria via an oral route, considering

(36:01):
it's difficult for most pathtides to even act on cells,
let alone go inside the cell and reach the mitochondria
to work. So I know that some peptides are very
good orally for example lorazatide BBC on five salven kpv,

(36:21):
but some of the more specific peptides that with intrasalular
sorry within the cells or intracelluar exalular I don't necessarily
think that these should be made oral. And to make
the distinction that you were saying, the peptides that are
injectable typically are between four and fifty in chain land,

(36:44):
and then the oral peptide bioregulators developed by doctor Carvinston
between two and four in chain land. For anyone watching
the distinction comes from the chain land for the amount
of amino acids in the chain. So that's typically the
hard line that we put ye.

Speaker 1 (37:02):
Yes, So going back to the cymosene alpha that's you know,
historically originally was targeting for the immune system. Correct.

Speaker 2 (37:13):
Yeah, it's twenty eight amino acids long, and actually it's
a bioidentical peptide. So you're born with timos and alpha one,
so your body makes thimost and alpha one as a
regular part of homeostasis. And as you age or you
become you know, impacted by toxins, or maybe you become

(37:33):
chronically sick with a virus, something like long covid or
lime disease or mol toxicity, your natural indulgenous production of
thymosin alpha one decreases and you have thymic involution and
thymaxnessence lone natural killer cells. It's like a domino effect.
So when you use dimos and alpha one as a

(37:54):
bioidentical supplement and you inject this as a peptide, all
you're doing is invoking the immune cascades that should already
be occurring in your body, but it's not because you're
not well.

Speaker 1 (38:07):
Right, Yeah, I think a lot of people who have
had long COVID have been resorting to building back your
immune system using that peptide.

Speaker 2 (38:17):
Oh yeah, yeah, it's super common in the long COVID world.

Speaker 1 (38:21):
And BPC one fifty seven is you know, that's probably
the most prevalent, and that's actually made in your gut.
That's why there are two forms of BPC one fifty seven.
One it targets your joint health and the other one
targets your gut health. And so you can actually take
one peptide and basically try to get results on two fronts.

(38:44):
But what do you think of that peptide? Have you
seen it work with some of the people that you
work with.

Speaker 2 (38:51):
Yeah, I really like BPC one pat seven. So it's
primarily spoken about in disgust for the gut and also
for ligaments and soft tissue and joints, as you said,
but also it actually blocks eMac so it actually has
been proven to basically repair the voltage gated ion channels

(39:14):
within cells. So yeah, it's very beneficial at the salular level,
and also it's neuroprotective. It actually balances the dopamine and
serotonin receptors, and it's also very good for the vegus
new As you said, all of the peptides are omnipotent, pluripotent,

(39:37):
pleotropic in nature, so you know they have so many
different benefits, ten plus benefits per peptide. So if you
take a staff of peptides, so you take five different
peptides all in one protocol, you're going to have, you know,
so many benefits like ten to the to a high

(39:57):
numerical value because they're all going to be synergistic and
coinciding together.

Speaker 1 (40:03):
So which which would what would you stack with BPC
one fifty seven?

Speaker 2 (40:09):
I would stack full fragment simosin b to four, otherwise
known as TB five hundred. Yeah, so I would also
stack GHK cus wow the copper pep exactly, and then
I would combine a growth hormone releasing pep dyde either
either something like c JC one two nine five blanded

(40:31):
with IPA morale in or either of those on their own,
or something like Sir Moralan as well, right hacka morale
and Tessa moralean. I don't, I don't. I haven't heard
that many good reviews about m K six seven seven.
I think I've heard it's a pretty m it's I've

(40:54):
heard it. It gives bad side effects, so I tend
to stick to the morale and growth hormone releasing tides.

Speaker 1 (41:02):
Yeah, and so this obviously a hot subject today is
the semi glue tides and the how do you feel
about people taking the semi glue tides.

Speaker 2 (41:18):
So I think that they've been wrongly villainized, and I
think that taken in the correct context at the at
a conservative dosage, at a conservative frequency, alongside a healthy
high protein diet, alongside high intensity workouts, alongside tantagrams of

(41:42):
creatine every day, alongside other anabolic healing PEP tides. So personally,
I don't recommend a GLP without recommending a growth horm
and releasing PEP tide taken alongside a GLP, because that
more or less offsets the muscle wasting. So there's a
lot of strategies that can be overcome when taking the glps.

(42:06):
And I think that you know those medications, they went
like to the masses, right, And whenever you have something
for the masses, you also have the media blowing the
medication out of proportion, especially with the celebrity the celebrity
paparazzi photos of celebrities who had taken the medication and

(42:28):
then they were looking very gaunt. And I think it
became a almost like a political statement. It became very
you know, political as well. And I think that it
was blown out of a portion. And I think when
used correctly, those are very good amino acid chains. And
I in my practice, I've never had someone come back

(42:48):
and say I had this really bad side of fact,
this went wrong. You know, I've had very good success.
And I think a lot of practitioners who truly used
glps and how they're meant to be used, I think
they feel the same way.

Speaker 1 (43:01):
And just for everyone to understand, b l P is
a synonym for the semi glue tide. It's a g.

Speaker 2 (43:08):
L P one, right, yeah, exactly.

Speaker 1 (43:11):
And so what does g LP stand for?

Speaker 4 (43:14):
A gamma's lucagon like pathway, dilecogen like pathway.

Speaker 2 (43:26):
I don't, I don't. I don't use them too often.
I'm focused on the immune system. That's kind of my
brad and butter. But when I do use g LPs,
you know, I consult my colleagues and and we've never
had a boy experience. Well.

Speaker 1 (43:46):
Also, let's not forget that the Insulin resistance is one
of the biggest causes of weight gain, and so the
original purpose of the g l P one semi gluey
is for or insulin control exactly, so that in itself
it could help people to lose weight if they get

(44:07):
that under control their blood sugar. So, yeah, what do
you feel though about the people that come back and
say I have to do I have to stay on
this from my entire life.

Speaker 2 (44:22):
Yeah, I got that question from almost one in every
three individuals who are interested in peptides. The way I
explain it is that peptides are an arm of regenerative medicines.
So the peptides actually do regenerate healthy signaling cllular cascades

(44:43):
within the cells, so they regenerate healthy communication, healthy salular communication.
In theory, this should rebuild a new baseline level of
health for you during the peptide therapy. And if you
look after yourself and you maintain a very good lifestyle,
a good diet, and you should not really receive any

(45:07):
diminishing returns when you finish the peptide therapy. So you know,
you shouldn't have to be very dependent on the paptides.
You should be able to maintain more or lass that
baseline level of health that you've accomplished during the peptides.
So I always say, you know, the peptides, they're not

(45:27):
They don't act like a drug, so your cells don't
become dependent on them, so there's no diminishing returns. But
if you use the peptides and then when you stop,
you fall back into old habits, you get bitten by
a tick, you go, you'd start living in a moldy environment.
You know, you pick up an infectious disease. You know,
maybe you go through some psychosomatic stress and you become

(45:50):
inflamed again. Then your cells signaling capacity will eventually begin
to drop, and it may seem like you need to
become dependent on paptides, but it's not. Because the people
who maintain their healthy lifestyle and don't become inflamed, you know,
they're not dependent on pap tides. And usually the first
cycle to get them to that baseline to hit their goals,

(46:13):
you know, gets them there, and then from that they
actually use paptized as a hobby and as a way
to stay optimized or slowly tweak on their goals.

Speaker 1 (46:23):
If someone wants to lose just five or ten pounds.
Would you ever let them usually semi gluta.

Speaker 2 (46:32):
Yeah, you can do for example, one injection once every
two weeks.

Speaker 1 (46:38):
Is that is that considered micro dosing? Yeah?

Speaker 2 (46:41):
It is.

Speaker 1 (46:44):
How much in that one dose that you do every
two weeks.

Speaker 2 (46:48):
So I typically use the latest GLP and it's a
triple agonist and it's called ratitrue Tide. So I've I've
kind of moved on from the salmon glue tie, which
is the Ozambic and the gobi, which is theatre's appetite,
and I tend to use the ratitrude Tide. It's a

(47:08):
pretty like bleeding edge glps. It's a triple agonist, and
that one we use it as when we use it
at one thousand, two hundred and fifty mcg beginning and
a very conservative dosage of maybe once every two weeks,
and then from there you can build up because a

(47:29):
lot of people, they have a lot of resistance with
these glps and it's always better to, you know, start
the person very very slow, just just to reassure them,
make them feel comfortable, and once they may realize that
they're not gonna blow up after the injection, you can
slowly start increasing them.

Speaker 1 (47:49):
Is that intramuscular, the injection.

Speaker 2 (47:53):
It can be. So there's a few different injection sites.
You can do the fire, you can do like the
love handle, upper glute tried and try agone, you can
do the you can do around the valley button. Personally,
for me, I've always preferred to inject in my glute trygone.

(48:14):
But I know a lot of people inject around the
valley button, which would be considered subcutaneous career.

Speaker 1 (48:21):
So, can people work with you, Jessica if they're interested at.

Speaker 2 (48:28):
With cell medicine, Yeah, yeah, for sure. So I'm based
in Dubai and I am taking on clients at a
limited capacity because I'm doing my masters and I'm also
building out a few Pepti brands. But I am taking
on clients and also we have I have my main
partner clinic in London, so anyone in the UK can

(48:51):
go to the clinic in London and can be seen
face to face. And I also have some partner in
clinics also in Tokyo and here in Dubai as well,
and also in Switzerland too. So what's the name of
the clinic, Oh, the one in London, It's called Neutro
Neutral Clinic.

Speaker 1 (49:11):
And U tro neutro.

Speaker 2 (49:14):
Yeah, and you U t r O. That's right. But
I can do I can do Talahal or we can
we can see you in London if you prefer more
hands on service.

Speaker 1 (49:26):
Right, And so if somebody's in the US, though, which
is you know, probably seventy percent of our viewers, they
would have to do telemedicine if they're not coming to
London or Dubai or Geneva.

Speaker 2 (49:38):
Yeah. I've seen more than probably four hundred clients now
via Talahal Palam Madison, So I can definitely see people
in the US. I can get the PAPTI shipped to
you within the US. I have very good suppliers within
the US. I can we can do everything remotely. I

(49:58):
have all of my professional qualifications on my LinkedIn, I
have client testimonial, video testimonials on my Twitter, will act
on Instagram, on YouTube, and also I think we're going
to link one of my presentations at the bottom of
the podcast as well, so you can also see my
written work and you can you can have a deep

(50:20):
dive into peptides for biological age and oral biregulated for
biological age as well.

Speaker 1 (50:26):
Yeah, we're gonna I think what we'll do since we're
not doing a video today. I think what we're going
to do is have you put this, We'll put this
in the show notes your presentation.

Speaker 2 (50:35):
Yeah.

Speaker 1 (50:36):
Cool, So I'm saying that on air right now so
that my assistant makes sure that she gets the presentation
from you and then adds it to the show notes
for our viewers. So if you'll take care of that
with Roxanne after the show, I would appreciate it.

Speaker 2 (50:53):
Amazing.

Speaker 1 (50:54):
Yeah, So what do you require when you start working
with a client or patient? What do they have to
give you? If it's tell and medicine.

Speaker 2 (51:05):
I mean, I'm pretty flexible, so I don't necessarily believe
that peptides should be dependent on blood test results. There's
nothing really in a blood test result that would say, okay,
you have this market elevated or decreased, So therefore we
need to use BPC one five salent. And I think

(51:26):
that's a common misconception of clients. They think that they
need to get a whole battery of tests for peptides,
whereas actually I like to be a bit more open
minded and just kind of I will ask, you know,
a relatively basic intake form. So what are your goals,
what are your symptoms, what you feel intuitively you're struggling with,

(51:47):
you know, what is your past, what other therapies have
you tried? And from that I can put together a
pretty in depth protocol, typically five to six injactibles, one
to two oral. We can also then use one to
two intrinasal and then also depending on the investment that

(52:07):
someone would like to make into the protocol, as in
the peptide course, we can also add the bioregulators in
there as well, so you know, you don't really need
too much to start peptides because there's no correlation between
a task market and a specific peptide.

Speaker 1 (52:27):
Have you ever experienced any negative side effic where somebody
you know should never take a pep tide in terms
of their.

Speaker 2 (52:37):
Health condition, not thus far. So the main body of
my work is looking at models of immunocompromisation, so that
is typically within that bracket, are you know, chronically toxic,
chronically sick people with mold illness, with lime disease. Those

(53:01):
people are very sensitive individuals, and they're very sensitive to
supplements and you know, even to just chemicals in their
daily environment. And all of those people have tolerated peptides
extremely well and have done very well on the peptides.
I have had a few people, a handful of people

(53:23):
who have been treatment resistant. So no matter you know,
what peptides we've used, we haven't managed to get the
results that we've been looking for. But this can be
attributed to maybe biofilms, because if you have biofilms around
your impacted area of cells, it's going to be difficult,

(53:43):
difficult to get any active into those cells. So I
have had people who've been treatment resistant, but you know,
we have tried all the way and we have got
in some way, but you know, not the same results
as the majority of my clients.

Speaker 1 (53:58):
And how are you defining by film?

Speaker 2 (54:02):
So biofilm is typically a reservoir of I think it's
made up of chiten. Uh, So you know, chiten is
like this gelatinous glue that these bacterial, viral, fungal, parasitic
reservoirs they all come together and they make these biofilms.

(54:25):
It's very common in long standing gut issues, in U
T I issues, bladder issues. It's actually dary common for
the E. N T as well, and also the COVID
virus was known to have a very high biofilm generating
you know genome's studies on that.

Speaker 1 (54:46):
Now and how does one know that they have that condition?

Speaker 2 (54:51):
If you have a biofilm, if you're you know, dary
treatment resistant and you have been for years, and you're
symptoms come in waves, cyclical waves, so you know every
three months or every six months, you know, very cyclical
waves almost like correlated to the moons and the seasons changing,

(55:15):
then you're more likely to have a biofilm. So if
you have a symptom increase, then around these cyclical waves,
you're more likely to have a biofilm because bacteria and
all the living pathogens in the biofilm have their own
life cycle. When this life cycle goes through its stages,
they break out on the biofilm and they cause an

(55:35):
increase in symptoms. A whole it's a whole other, very
scary topic.

Speaker 1 (55:40):
Yeah, Well, I know you've done a lot of work
with mold and lime, So is that a clue to
you right away with somebody who's dealing with mold or
lime disease that they also have the biofilm issues that
are going to prevent any treatment from being efficacious.

Speaker 2 (56:01):
Yeah, it can. It can depend. So line itself is
known to cause a lot of fibrotic cysts, so line
actually will make cysts and it will hide in the
cysts and they mix these with fibrin, so that can
be pretty difficult. And then also, yeah, people people who

(56:21):
are you know, chronically sick, you know, they've been proven
to have very high bio biofilm reservoirs. So I do
see that commonly. And you know, if someone is sorry,
treatment resistant, you you can kind of get a sense
for it, and you can you can put them on
maybe two to three months of biophone busters before starting

(56:43):
any paptech therapy protocol.

Speaker 1 (56:46):
Mh so J justica. They just they just flagged me
that we're running out of China, And I want to
ask you a couple other questions before we go. What
do you think is the few sure of peptide and
peptid bioregulators.

Speaker 2 (57:05):
So actually, I think the human genome has around three
hundred thousand peptide is available to code to translate into proteins,
which are what you know, peptides are anything that's made
up of an amino acid is a protein. And really,
I mean, how many do we actually have on the

(57:27):
bench on the bad side. So you know how many
are community available for people to buy. I think thirty
five maybe not even that. The bioregulator is a twenty one,
so it's under one hundred peptides and bioregulators combined that
you can go on the internet or get prescribed and

(57:48):
treat yourself with. So I think the future is actually
figuring out which amino acid chains they're going to bring
about the greatest success to human health, creating more of
those reducing barriers between in vitro to vitro to human
clinical trials of these amino acid chains, and then also

(58:12):
exploring peptides from b venom to the d MT frog two,
you know, other animals who have had like tribal medicinal impacts,
and also bringing those peptides to humans as well, because
I know in traditional Chinese medicine, b venom is huge, right,

(58:35):
and I really agree with b vanoms, so you know,
there should be a b vanom peptide. There's also there
also should be a lot more peptides for people with
spinal cord injuries as well.

Speaker 1 (58:47):
Good point, Well, they're using stem cells for spinal cord injuries,
but there is. You're right, there's there are not a
lot of peptides to focus on the spinal cord.

Speaker 2 (59:00):
I wonder why that is or the brain. I mean,
we have three bro lisin and called taxin, but they're
not exactly super specialized. They're just blanded down pig and
cow peptides.

Speaker 1 (59:13):
M hm. So yes, good. How how can somebody who's
interested reach you?

Speaker 2 (59:24):
My website is Jessica Alana dot com, my email is
Jessica Jaska Alana dot com, and my Instagram is Jessica
Alana And I'm sure we'll have all of that in
the show notes and it'll also be the first slide
on my linked presentation as well. So yeah, you can
reach to me. You can either reach it out to
me via my email or you can use the contact

(59:48):
form on my website, or if you want to do
more of a deep dive, you can search me on LinkedIn.
You can search me on Twitter, on Instagram, on YouTube
you can see everything and all my proof of work.

Speaker 1 (01:00:00):
And Jessica, have you seen the latest issue of Top
Doctor Magazine?

Speaker 2 (01:00:07):
I don't think I have. I we don't get a
lot of exposure to medical magazines here in Dubai. It's
a very different community here.

Speaker 1 (01:00:19):
Well you can. I think you can view it online.
The reason I'm asking is that I didn't. You're writing
a monthly column for Top Doctor magazine and I just
did my first interview with a cover of Jay Campbell.

Speaker 2 (01:00:33):
Oh I love him.

Speaker 1 (01:00:34):
Yeah, So I would love if you would watch or
read the interview because he is now a co founder
of Biolongevity Labs, which is taking doctor Cavinson's research into
the US manufacturing of peptide bioregulators. So they yeah, peptides

(01:00:58):
as well, but and some some oral and mostly injectable.
But I think you find the interview fascinating if you
have a chance to catch it, or I could ask
for If you can't find it, let me know and
I'll have my assistant send you the link.

Speaker 2 (01:01:16):
In fact, I have a lot of respect for j
He had you know, he was He's basically the o
G of the peptide industry, So I have a lot
of respect for him. He was talking about pep tid's
like ten to fifteen years ago. Oh yeah, yeah.

Speaker 1 (01:01:34):
He wrote the Bible. He's been on my podcast couple
and I've been on his. So we did a mutual
reciprocal appearances, and then he stopped doing his podcast when
he became an entrepreneur in the in the startup world.
So we don't we're not doing the podcast with him recipically,

(01:01:56):
but we did select him as my first article. And
the reason is that because peptides have become such a
hot topic and he is like the granddad. He particularly testosterone.
He wrote the Bible, yeah, way back and I think
it was twenty ten or something. He wrote the Bible
before it was even such a hot topic. And that

(01:02:21):
that book his original book. He's written six different books.
But I told him, I said, Jay, I don't know
how you ever sleep because he's so prolific. But that
original testosterone Bible is still being used today.

Speaker 2 (01:02:37):
He's awesome.

Speaker 1 (01:02:39):
And he's not a medical doctor. He's a you know,
he's a just like Bill Lawrence and me and myself.
We're all real estate developers. Interesting. I morphed into the
functional medicine field, a longevity field, really through experiences in
our own personal lives, just like you did.

Speaker 2 (01:03:01):
Yeah, I don't. I wouldn't discredit anyone for not being
a medical doctor. I'm not a medical doctor. You know.
My bachelor's is biomedicine. My master's is longevity science. I
don't have a I'm not licensed to practice medicine. I
wouldn't discredit anyone for being a medical doctor. Knowledge is knowledge,

(01:03:21):
and if you can show true understanding and you can
help people and you'll gather, you'll gather people who trust
you and you'll help them. That's just how it goes.

Speaker 1 (01:03:30):
No. Yeah, and my good friend Lisa Tomati, who you
should be on her podcast called Pushing the Limits. I'll
introduce you. But she's not a medical dator, but she
does hyperbaric She has a whole chamber in her I
mean she has a number of different hyperbaric chambers than
her clinic. But she's another good example of people someone

(01:03:55):
like you just studied and studied and has had a
consulting practice. All right, Well we've run out of time,
and I just thank you so much. I wish you're
the absolute very best. I'm going to talk to you offline. Yeah,
these connections and and anything else we can I can
do for you or you can do for me, well

(01:04:16):
find the path forward.

Speaker 2 (01:04:18):
So well, thank you so much.

Speaker 1 (01:04:20):
And I'll let you know what happens with Bill Lawrence
and the next phase of the clinical trials. I'm really
looking forward to hearing you about your experience as you
progress forward with him.

Speaker 2 (01:04:33):
So I'm so excited. Yeah, we'll talk very soon. We
planned this for a while.

Speaker 1 (01:04:38):
Ask you, Jessica. You've been very patient with us, and.

Speaker 2 (01:04:44):
Oh you too.

Speaker 1 (01:04:45):
Thank you. All right, well you have a good night's sleep,
and thank you so much taking the time so late
in your evening to be with us, and my pleasure
cate all of your knowledge and sharing with us today.
Thank you again, Jessica.

Speaker 2 (01:05:00):
Thank you so much.

Speaker 1 (01:05:01):
Okay, bye, bye bye